Anti-CD20 therapies in pregnancy and breast feeding: a review and ABN guidelines

Rituximab for treatment of refractory multiple sclerosis relapses during pregnancy

(2021) Chris Hollen et al.   Multiple Sclerosis Journal

Natalizumab, Fingolimod and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis

(2021) Wei Zhen Yeh et al.   NEUROLOGY

Rituximab and Canakinumab Use During Lactation: No Detectable Serum Levels in Breastfed Infants

(2021) Nicole Bosshard et al.   Rheumatology and Therapy

Perinatal development of innate immune topology

(2021) Philipp Henneke et al.   eLife

COVID ‐19 Vaccine Response in People with Multiple Sclerosis

(2021) Emma C. Tallantyre et al.   ANNALS OF NEUROLOGY

Covid-19 treatments and vaccines must be evaluated in pregnancy

(2021) Allyah Abbas-Hanif et al.   BMJ-British Medical Journal

Pregnancy outcomes in anti-NMDA receptor encephalitis

(2020) Bastien Joubert et al.   Neurology-Neuroimmunology & Neuroinflammation

Outcome of pregnancies after onset of the neuromyelitis optica spectrum disorder

(2020) S.‐H. Kim et al.   EUROPEAN JOURNAL OF NEUROLOGY

Rituximab, MS, and pregnancy

(2020) Jessica B. Smith et al.   Neurology-Neuroimmunology & Neuroinflammation

Monoclonal antibody treatment during pregnancy and/or lactation in women with MS or neuromyelitis optica spectrum disorder

(2020) Andrea Ines Ciplea et al.   Neurology-Neuroimmunology & Neuroinflammation

Transfer of monoclonal antibodies into breastmilk in neurologic and non-neurologic diseases

(2020) Sara C. LaHue et al.   Neurology-Neuroimmunology & Neuroinflammation

Dysfunctional Immune System Reconstitution After Rituximab Exposure In Utero

(2020) Rebecca Clark et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Myasthenia gravis and pregnancy

(2020) Kavita M. Grover et al.   MUSCLE & NERVE

Ocrelizumab exposure in the second trimester of pregnancy without neonatal B-cell depletion

(2020) Mary Rolfes et al.   Multiple Sclerosis and Related Disorders

Disease activity in pregnancy and postpartum in women with MS who suspended rituximab and natalizumab

(2020) Neda Razaz et al.   Neurology-Neuroimmunology & Neuroinflammation

Pregnancy outcome in patients with multiple sclerosis treated with Rituximab: A case-series study

(2020) Maral Seyed Ahadi et al.   Multiple Sclerosis and Related Disorders

Anti-CD20 therapies and pregnancy in neuroimmunologic disorders

(2020) Tania Kümpfel et al.   Neurology-Neuroimmunology & Neuroinflammation

Minimal breast milk transfer of rituximab, a monoclonal antibody used in neurological conditions

(2019) Kristen M. Krysko et al.   Neurology-Neuroimmunology & Neuroinflammation

Updated pharmacological management of rheumatoid arthritis for women before, during, and after pregnancy, reflecting recent guidelines

(2018) Kieran E. Murray et al.   IRISH JOURNAL OF MEDICAL SCIENCE

Antibody Profile of Colostrum and the Effect of Processing in Human Milk Banks: Implications in Immunoregulatory Properties

(2017) Claudio Rodríguez-Camejo et al.   JOURNAL OF HUMAN LACTATION

High risk of postpartum relapses in neuromyelitis optica spectrum disorder

(2017) Eric C. Klawiter et al.   NEUROLOGY

Low level of Rituximab in human breast milk in a patient treated during lactation

(2017) Yngvill Bragnes et al.   RHEUMATOLOGY

The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy

(2016) Geoffrey C. Nguyen et al.   GASTROENTEROLOGY

Safety of Repeated Open-Label Treatment Courses of Intravenous Ofatumumab, a Human Anti-CD20 Monoclonal Antibody, in Rheumatoid Arthritis: Results from Three Clinical Trials

(2016) Emilia Quattrocchi et al.   PLoS One

Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial

(2011) Ludwig Kappos et al.   LANCET

Pregnancy outcomes after maternal exposure to rituximab

(2010) E. F. Chakravarty et al.   BLOOD